New Solutions for Weight Loss and Blood Sugar Control
For decades, obesity and insulin resistance have been on the rise among aging Americans. Until recently, most solutions to this problem have been diet oriented.
But lately, there are exciting developments in the fight against obesity.
We’re talking about two medications that have historically been used to treat type 2 diabetes. It turns out that these medications are also helpful for weight loss, even among people who are not diabetic.
Metformin: A Well-Tested Ally in Diabetes Management
Metformin has been used since 1994 for blood-sugar control. It reduces sugar in the blood by improving insulin sensitivity.
The primary benefits of metformin include:
- Safe and effective blood sugar control
Metformin is a first-line treatment for type 2 diabetes. It provides more effective blood sugar regulation than diet restriction alone.
- Weight management
Many individuals experience modest weight loss while taking metformin.
- Cardiovascular protection
Studies suggest that metformin may help to prevent cardiovascular disease.
While metformin is well-tolerated by most people, some patients experience gastrointestinal distress while taking it. However, these symptoms usually subside over time.
Semaglutide: A New Weapon for Appetite Control and Blood Sugar Management
Semaglutide was first approved in 2017 as a treatment for type 2 diabetes. However, it was more recently approved as a weight loss drug.
The primary benefits of semaglutide include:
- Appetite suppression
Semaglutide reduces appetite and slows the rate at which your stomach empties after eating.
- Blood sugar control
Semaglutide improves blood sugar control and helps to improve insulin sensitivity.
- Weight loss
Clinical trials have shown that patients using semaglutide can achieve weight loss that’s on a par with weight loss surgery.
Like metformin, semaglutide can cause gastrointestinal issues. Usually these symptoms are transient, but they can be challenging for some individuals. Gradual titration of dosing can help to prevent and alleviate these symptoms.
Although rare, pancreatitis and thyroid tumors have been associated with semaglutide use. Patients with a history of pancreatitis and patients with a personal or family history of medullary thyroid cancer are usually not candidates for this medication.
What You Need to Know
Metformin and semaglutide are powerful tools in the quest for effective appetite suppression, blood sugar control, and weight loss. They offer new hope for patients who have struggled to achieve weight loss through calorie restriction alone.
Renew Youth is here to guide you toward the best solutions for good health and healthy aging. To schedule a free consultation, call us at 800-859-7511 or use our contact form to set up your free 30-minute consultation.